Direkt zum Inhalt
Merck

Differentiation of human pluripotent stem cells into pancreatic duct-like organoids.

STAR protocols (2021-12-18)
Markus Breunig, Jessica Merkle, Michael Karl Melzer, Sandra Heller, Thomas Seufferlein, Matthias Meier, Meike Hohwieler, Alexander Kleger
ZUSAMMENFASSUNG

The recapitulation of human developmental processes and pathological manifestations requires access to specific cell types and precursor stages during embryogenesis and disease. Here, we describe a scalable in vitro differentiation protocol to guide human pluripotent stem cells stepwise into pancreatic duct-like organoids. The protocol mimics pancreatic duct development and was successfully used to model the onset and progression of pancreatic ductal adenocarcinoma; the approach is suitable for multiple downstream applications. However, the protocol is cost- and time-intensive. For complete details on the use and execution of this protocol, please refer to Breunig et al. (2021).

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Accutase® -Lösung, sterile-filtered, suitable for cell culture
Sigma-Aldrich
LDN193189 -hydrochlorid, ≥98% (HPLC)
Sigma-Aldrich
Dorsomorphin, ≥98% (HPLC)
Sigma-Aldrich
SANT-1, ≥98% (HPLC), powder